Letizia Procaccio - Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IOV-IRCCS

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 51 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Survival Analysis of the Non-Metastatic Cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real World: Multi-Institutional Based Survey of Adjuvant and First-Line Pancreatic Ductal Adenocarcinoma Treatment in Italy (GARIBALDI)

M. Reni,M. Milella,F. Bergamo, M. Di Marco,E. Giommoni,G. G. Cardellino,L. Cavanna, M. Bonomi,F. Zustovich,S. Bozzarelli,F. Salmaso,M. Spada,G. Orsi,M. Macchini,J. Insolda,L. Procaccio, A. Santoni, I. De Simone, L. Caldirola,F. Galli,C. Pinto

ESMO OPENno. 1 (2025)

Cited0Views0WOSBibtex

Exploring External Validity of Chemotherapy for Pancreatic Ductal Adenocarcinoma in Real Life

Michele Reni,Guido Giordano,Marco Audisio,Giulia Orsi,Marina Macchini, Stefania Maria Gobba,Ilario Rapposelli, Antonio Lucenti,Giovanna Luchena,Luca Faloppi,Fable Zustovich,Vincenzo Ricci,Massimiliano Cergnul,Vincenzo Formica,Letizia Procaccio, Valeria Baccolini, Assunta Briccolani,Stefano Cascinu,Umberto Peretti

DIGESTIVE AND LIVER DISEASEno. 1 (2025): 104-110

Cited0Views0WOSBibtex

303P Biliary Tract Cancers (BTC): Descriptive and Prognostic Analyses from a Large Real-World Dataset: the BITCOIN 2 Study

M.D. Rizzato,V. Angerilli,A. De Rosa,D. Sacchi,G. Barsotti,V.M. Piva,M.C. De Grandis,C. Soldà,R. Intini,A.A. Prete, M. Sabbadin,R. Cerantola,K. Cerma,L. Procaccio,C. Ceccon,E. Perissinotto,E. Carcea,S. Lonardi,F. Bergamo,M. Fassan

Annals of Oncology (2024): S128

Cited0Views0Bibtex

337P Real-life Second-Line Therapies Outcome in Metastatic Pancreatic Cancer (mpdac) Patients Previously Treated with Gemcitabine Plus Nab-Paclitaxel (Gem-Nab): an Italian Multicenter Study

L. Procaccio,G. Giordano,G. Barsotti,C. Zecchetto,F. Bergamo,M. Landriscina, M. Masucci,G. Di Paolo,F. De Vita, V. Gebbia, A. Mancino,G. Ricagno,R. Bianco,S. Noventa,G. Lo Re,E. Vasile,S. Sperotto,S. Casalino,V. Merz,S. Lonardi

Annals of Oncology (2024): S141

Cited0Views0Bibtex

Supplementary Tables S1-S19 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Video S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S3 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn